The Supreme Court's interpretation of the biosimilars statute and the value of certainty
Nature Biotechnology 35, 916 (2017).
doi:10.1038/nbt.3977
Authors: Irena Royzman & Nathan Monroe-Yavneh
The Supreme Court's decision in Sandoz v. Amgen introduces uncertainty into provisions that many viewed as necessary and enforceable, but its impact may ultimately be modest.
Source: Nature Biotechnology - Category: Biotechnology Authors: Irena Royzman Nathan Monroe-Yavneh Tags: Feature Source Type: research
More News: Biotechnology | Legislation